Nigeria Named Early Adopter Of Long-Acting HIV Drug As Global Fund Targets Wider Prevention
Nigeria has been selected as one of nine early adopter countries for Lenacapavir, a long-acting injectable drug designed to prevent HIV infection, with 179,700 doses expected by 2028. The announcement was made on Tuesday in Abuja by the Global Fund’s Country Director, Jean-Thomas Nouboussi, during the official launch of the drug. He said the rollout…
